Accolate and Revlimid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Accolate (zafirlukast) and Revlimid (lenalidomide). Common drug interactions include bronchitis among females and interstitial lung disease among males.

The phase IV clinical study analyzes what interactions people have when they take Accolate and Revlimid. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Accolate?

Accolate has active ingredients of zafirlukast. It is often used in asthma. eHealthMe is studying from 4,220 Accolate users. Check the latest studies of Accolate.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

On Jul, 31, 2026

16 people who take Accolate and Revlimid together, and have interactions are studied.

Accolate and Revlimid drug interactions.

What are the common drug interactions of Accolate and Revlimid, by gender? *:

female:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Eye pruritus (eye itching)
Headache (pain in head)
Lethargy (tiredness)
Malaise (a feeling of general discomfort or uneasiness)
Ocular hyperaemia (an abnormally large amount of blood in eye)
Rash
Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
Dementia alzheimer's type (loss of mental ability with alzheimer's symptom)
Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)

male:

Interstitial lung disease
Pulmonary toxicity (side effects on the lungs)
Respiratory failure (inadequate gas exchange by the respiratory system)
Swelling
Death
Anaemia (lack of blood)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Diarrhoea
Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Accolate and Revlimid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Eye pruritus (eye itching)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)
Infection
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Performance status decreased
Dermatitis bullous (inflammation of the skin characterized by the presence of bullae which are filled with fluid)

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 12.50%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 6.25%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 6.25%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Accolate and Revlimid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously